1. Mesoblast Limited (NASDAQ:MESO)
With strong revenue growth projections, Mesoblast Limited (NASDAQ:MESO) secures a spot on our list of the best long-term ASX stocks to buy right now.
As of April 15, 2026, all covering analysts remain bullish on Mesoblast Limited (NASDAQ:MESO), with a consensus price target of $32.5, implying upside potential of 106.5%.
That positive sentiment is largely driven by Ryoncil’s growing clinical potential and expanding commercial opportunity.
On April 7, 2026, Mesoblast Limited (NASDAQ:MESO) announced that the FDA granted IND clearance to advance directly into a registration trial of Ryoncil for Duchenne muscular dystrophy, representing an important milestone in the context of the therapy’s potential market expansion beyond its existing approval for pediatric steroid-refractory acute graft-versus-host disease.
In addition to this, the upcoming study is expected to enroll 76 patients aged 5 to 9, with time-to-stand at nine months set as the primary endpoint. Management is also collaborating with Parent Project Muscular Dystrophy to aid patient identification and raise awareness of the trial, which should support execution.
That pipeline progress is also supported by early signs of commercial traction.
On April 6, 2026, Mesoblast Limited (NASDAQ:MESO) reported Ryoncil net sales of $30.3 million for the March quarter, with first-year launch revenue nearing $100 million. Management noted that these proceeds are strengthening the company’s balance sheet and helping finance label expansion efforts and late-stage clinical programs, further supporting the company’s long-term growth outlook.
Mesoblast Limited (NASDAQ:MESO), together with its subsidiaries, develops regenerative medicine products in Australia, the US, Singapore, and Switzerland. The company’s proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
While we acknowledge the potential of MESO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MESO and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 Stocks Under $5 That Will Explode and 10 Best AI Energy Stocks to Buy in 2026.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
